Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer

Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

(2014) Toru Aoyama et al.   ANNALS OF SURGICAL ONCOLOGY

Impact of infectious complications on gastric cancer recurrence

(2014) Tsutomu Hayashi et al.   Gastric Cancer

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery

(2011) Takanobu Yamada et al.   Gastric Cancer

Japanese classification of gastric carcinoma: 3rd English edition

(2011)   Gastric Cancer

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Effects of Ghrelin Administration After Total Gastrectomy: A Prospective, Randomized, Placebo-Controlled Phase II Study

(2010) Shinichi Adachi et al.   GASTROENTEROLOGY

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY

Body mass index is negatively correlated with respiratory muscle weakness and interleukin-6 production after coronary artery bypass grafting

(2009) Yuki Iida et al.   JOURNAL OF CRITICAL CARE

Ghrelin Induces Abdominal Obesity Via GHS-R-Dependent Lipid Retention

(2009) Jeffrey S. Davies et al.   MOLECULAR ENDOCRINOLOGY

Gender-Related Differences in Muscle Injury, Oxidative Stress, and Apoptosis

(2008) CHAD KERKSICK et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE